This content is from: Patents
Merck’s $200m patent damages award voided after “misconduct”
Northern District of California judge rules Merck forfeited its right to assert patents against Gilead because of "unclean hands" and "numerous unconscionable acts", voiding the second-largest US patent damages award of 2016 so far
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here